Head and Neck Neoplasm — Trials

Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 2,491 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03358472	Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)	completed	Phase 3	89	Incyte CorporationINDUSTRY	14	Sep 29, 2026	clinicaltrials
NCT05057247	Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC	completed	Phase 2	26	Kartik Sehgal, MDOTHER	1	Sep 29, 2026	clinicaltrials